Showing results (371-380 of 2,556) with videos related to

Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|May 10, 2014
Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritisChadi Rakieh, Philip G Conaghan
Therapeutics and Clinical Risk Management|May 3, 2014
Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Ruth M Tarzi, Charles D Pusey
Therapeutics and Clinical Risk Management|October 4, 2016
Association of low serum aluminum level with mortality in hemodialysis patientsChing-Wei Hsu, Cheng-Hao Weng, Cheng-Chia Lee, et al.
Therapeutics and Clinical Risk Management|May 2, 2012
Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)Candace Y Hooper, Winter J Smith
Therapeutics and Clinical Risk Management|May 2, 2012
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary diseaseSebastian Michel, Amir K Bigdeli, Andres Beiras-Fernandez, et al.
Therapeutics and Clinical Risk Management|September 13, 2014
Magnetoledtherapy in the treatment of wounds after surgical procedures of the knee jointJarosław Pasek, Tomasz Pasek, Aleksander Sieroń
Therapeutics and Clinical Risk Management|October 21, 2014
Is hypoalbuminemia a prognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients?Kamal Hassan, Hassan Fadi
Therapeutics and Clinical Risk Management|October 21, 2014
Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary diseaseHéctor González-Pacheco, Jesús Vargas-Barrón, Maite Vallejo, et al.
Therapeutics and Clinical Risk Management|September 18, 2014
Application of caspofungin in China compared with amphotericin B and fluconazoleChunyu Zhang, Jiaoying Cheng, Yan Jiang, et al.
Pageof 256